NCT00801515View on ClinicalTrials.gov

A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

NO_LONGER_AVAILABLEEXPANDED_ACCESS

Timeline

Start Date

August 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

HIV

Interventions

DRUG

Maraviroc

150 mg twice per day

Trial Locations (1)

H3G 1A4

Pfizer Investigational Site, Montreal

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

ViiV Healthcare

INDUSTRY